Načítá se...
Evidence for fatty acids mediating CL 316,243-induced reductions in blood glucose in mice
CL 316,243, a β(3)-adrenergic agonist, was developed as an antiobesity and diabetes drug and causes rapid decreases in blood glucose levels in mice. The mechanisms mediating this effect have not been fully elucidated; thus, the purpose of the current study was to examine the role of fatty acids and...
Uloženo v:
| Hlavní autoři: | , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
American Physiological Society
2014
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4187028/ https://ncbi.nlm.nih.gov/pubmed/25096179 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1152/ajpendo.00287.2014 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|